Top3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Top3 protein, a key enzyme involved in DNA processing and other cellular functions. These inhibitors function by binding to the active site of the Top3 protein, where they block its interaction with DNA or other necessary substrates. By occupying the active site, Top3 inhibitors prevent the enzyme from catalyzing its usual reactions, thereby halting its biological function. In some cases, these inhibitors may also bind to allosteric sites, which are regions of the protein separate from the active site. Binding to allosteric sites induces conformational changes in the protein's structure, which can diminish or completely inhibit its activity. The interaction between Top3 inhibitors and the protein is typically driven by non-covalent forces, such as hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions, which help to stabilize the inhibitor-protein complex.
The structural diversity of Top3 inhibitors is key to their function, with their molecular frameworks tailored to interact with the specific regions of the Top3 protein. These inhibitors often incorporate functional groups such as hydroxyl, amine, or carboxyl groups, which allow them to form hydrogen bonds with residues in the active site of the protein. Additionally, the presence of aromatic rings and heterocyclic structures within Top3 inhibitors enhances hydrophobic interactions with non-polar areas of the protein, thereby increasing their binding affinity and stability. The physicochemical properties of these inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure that they can bind effectively to the Top3 protein and remain stable in different biological environments. This balance between hydrophilic and hydrophobic properties allows Top3 inhibitors to achieve strong, specific interactions with the protein, ensuring their ability to modulate the protein's activity under various conditions.
Items 1 to 10 of 21 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits Top3 by trapping the enzyme-DNA complex during DNA replication. This prevents Top3 from resolving DNA topological structures, leading to DNA damage and inhibition of Top3 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits the tyrosine kinase activity of BCR-ABL, disrupting signaling pathways in chronic myeloid leukemia. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Competes with estrogen for binding to estrogen receptors in breast tissue, blocking estrogen-induced cell growth. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits Top3 by forming a ternary complex with the enzyme and DNA, preventing the resealing of DNA breaks. This traps Top3 on DNA, leading to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
(+)-Irinotecan | 97682-44-5 | sc-269253 | 10 mg | $62.00 | 1 | |
Irinotecan inhibits Top3 by forming a stable ternary complex with the enzyme and DNA, preventing the re-ligation of DNA breaks. This traps Top3 on DNA, leading to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Inhibits multiple kinases, including RAF kinases and VEGFR, suppressing tumor cell proliferation and angiogenesis. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Targets the epidermal growth factor receptor (EGFR), blocking downstream signaling and inhibiting cell growth in lung cancer. | ||||||
Dexrazoxane | 24584-09-6 | sc-252669 | 5 mg | $112.00 | 1 | |
Dexrazoxane inhibits Top3 by chelating metal ions required for enzyme activity, thereby preventing Top3-mediated DNA re-ligation. This leads to the accumulation of DNA breaks and inhibition of Top3 activity. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone inhibits Top3 by intercalating into DNA and stabilizing the enzyme-DNA complex, preventing the re-ligation of DNA breaks. This traps Top3 on DNA, leading to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Blocks androgen receptor signaling, inhibiting the growth of cells dependent on androgen stimulation. | ||||||